Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Kai Ozaki"'
Autor:
Kai Ozaki, Shingo Hatakeyama, Toshikazu Tanaka, Daisuke Noro, Noriko Tokui, Hirotaka Horiguchi, Yoshiharu Okuyama, Naoki Fujita, Teppei Okamoto, Akiko Okamoto, Yuichiro Suzuki, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Publikováno v:
BJUI Compass, Vol 3, Iss 2, Pp 139-145 (2022)
Abstract Objectives To investigate the eligibility for maintenance immunotherapy and its impact on the prognosis of advanced urothelial carcinoma treated with first‐line chemotherapy, as the selection biases of the eligible population in the JAVELI
Externí odkaz:
https://doaj.org/article/857c205233624511ba6c913939492daf
Autor:
Yusuke Ozaki, Takuma Narita, Shingo Hatakeyama, Toshikazu Tanaka, Kyo Togashi, Tomoko Hamaya, Kai Ozaki, Noritaka Ishi, Takuya Oishi, Noriko Tokui, Jotaro Mikami, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Publikováno v:
Translational Andrology and Urology. 12:161-167
Autor:
Yusuke Ozaki, Shingo Hatakeyama, Atsushi Imai, Jung Songee, Osamu Soma, Kai Ozaki, Naoki Fujita, Teppei Okamoto, Hiromichi Iwamura, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Publikováno v:
International Journal of Urology.
Autor:
Teppei Okamoto, Tatsuya Mikami, Yoshiharu Okuyama, Kai Ozaki, Chikara Ohyama, Jung Songee, Shingo Hatakeyama, Daichi Sasaki
Publikováno v:
International Urology and Nephrology. 54:9-16
PURPOSE To assess the influence of gut microbiome on overactive bladder (OAB) symptoms progression. METHODS This was a 3-year longitudinal study, Hirosaki in Japan. We assessed OAB symptoms and reviewed the medication records of each subject in 2016.
Autor:
Noriko Tokui, Hirotaka Horiguchi, Toshikazu Tanaka, Shingo Hatakeyama, Akiko Okamoto, Yoshiharu Okuyama, Daisuke Noro, Yuichiro Suzuki, Naoki Fujita, Hayato Yamamoto, Yasuhiro Hashimoto, Chikara Ohyama, Kai Ozaki, Takahiro Yoneyama, Teppei Okamoto
Publikováno v:
BJUI Compass, Vol 3, Iss 2, Pp 139-145 (2022)
Objectives To investigate the eligibility for maintenance immunotherapy and its impact on the prognosis of advanced urothelial carcinoma treated with first‐line chemotherapy, as the selection biases of the eligible population in the JAVELIN Bladder
Autor:
Kai Ozaki, Shingo Hatakeyama, Shintaro Narita, Kenichi Hata, Takafumi Yanagisawa, Toshikazu Tanaka, Kyo Togashi, Tomoko Hamaya, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Takahiro Kimura, Tomonori Habuchi, Chikara Ohyama
Publikováno v:
World journal of urology.
We compared the real-world efficacy and medical costs for treatment with upfront docetaxel (DOC) and abiraterone acetate (ABI) up to progression-free survival 2 (PFS2) in patients with metastatic hormone-sensitive prostate cancer (mHSPC).This multice
Autor:
Tomoko Hamaya, Shingo Hatakeyama, Kai Ozaki, Kazutaka Okita, Yasuhiro Hashimoto, Chikara Ohyama
Publikováno v:
Journal of Urology. 207
Autor:
Hiromichi Iwamura, Tohru Yoneyama, Hirotake Kodama, Kai Ozaki, Yusuke Ozaki, Kazutaka Okita, Sakae Konishi, Takuma Narita, Naoki Fujita, Yuta Kojima, Teppei Okamoto, Yuki Tobisawa, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Publikováno v:
Journal of Urology. 207
Autor:
Kai Ozaki, Shingo Hatakeyama, Tomoko Hamaya, Kazutaka Okita, Yasuhiro Hashimoto, Chikara Ohyama
Publikováno v:
International journal of urology : official journal of the Japanese Urological AssociationReferences. 29(4)
Autor:
Yoshimi Tanaka, Yusuke Ozaki, Fumitada Saitoh, Ken Fukushi, Yoshiharu Okuyama, Teppei Okamoto, Yuuki Miura, Kai Ozaki, Chikara Ohyama, Shingo Hatakeyama, Daichi Sasaki, Kengo Imanishi
Publikováno v:
Clinical and experimental nephrology. 26(2)
We investigated whether butyrylcholinesterase (BChE) was independently related to the overall survival (OS) of patients on maintenance hemodialysis (MHD). Baseline information, serum BChE level, and other laboratory data were collected from 295 patie